Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Tord Staffan Håkan Skogvall — CEO

Roles

PharmaLundensis AB Stockholm
CEO
23.09.2025 – 01.07.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
01.07.2026PharmaLundensis AB Stockholm
SoldDisposal
148,138SEK 0.40
SEK 59,492.22
↗
04.06.2026PharmaLundensis AB Stockholm
SoldDisposal
1,181,325SEK 0.14
SEK 165,385.50
↗
20.02.2026PharmaLundensis AB Stockholm
New shares (subscription)
200,000SEK 0.50
SEK 100,000.00
↗
01.10.2025PharmaLundensis AB Stockholm
SoldDisposal
223,693SEK 0.64
SEK 143,163.52
↗
24.09.2025PharmaLundensis AB Stockholm
Bought — open marketAcquisition
92,333SEK 0.19
SEK 17,543.27
↗
24.09.2025PharmaLundensis AB Stockholm
Bought — open marketAcquisition
63,017SEK 0.22
SEK 13,863.74
↗
23.09.2025PharmaLundensis AB Stockholm
Bought — open marketAcquisition
65,656SEK 0.20
SEK 13,131.20
↗